The Axon Guidance Molecule Netrin-4 is Expressed by Müller Cells and Contributes to Angiogenesis in the Retina
Authors
Affiliations
Retinal glial (Müller) cells are involved in a wide range of developmental mechanisms, including axon guidance and angiogenesis. This study was undertaken to explore whether Netrin-4, an axonal guidance molecule, is expressed by Müller cells and promotes angiogenesis-related activities. Netrin-4 was found through all retinal layers, and its expression was demonstrated in Müller cells, retinal pigment epithelium cells and bovine retinal endothelial cells (BRECs). Co-localization of Netrin-4 with Müller cell-specific molecules [cellular retinaldehyde-binding protein (cRALBP), vimentin] was observed in the ganglion cell layer, nerve fiber layer, and at the outer limiting membrane. Under hypoxic conditions, the release of Netrin-4 from Müller cells was increased, with mRNA levels upregulated in a hypoxia-inducible factor-1-dependent manner and dependent on the concomitantly induced release of vascular endothelial growth factor. These findings were consistent with an intensified immunofluorescence of Netrin-4 labeling in the postischemic retinas after ischemia-reperfusion. Netrin-4 stimulated BRECs to increase phosphorylation of the mitogen-activated protein (MAP) kinases, extracellular signal-regulated kinase (ERK)-1/-2, and p38, in a dose-dependent manner. Synthetic inhibitors of the MAP kinases were able to suppress Netrin-4-induced migration and proliferation of BRECs suggesting that both MAP kinases are differentially involved in Netrin-4-induced angiogenesis. Two receptors for Netrins, i.e., deleted in colorectal cancer (DCC) and uncoordinated-5-homolog 1 (Unc5H1), were detected in BRECs. DCC is at least partially required for Netrin-4-induced activation of ERK-1/-2. These data suggest that Müller glial cells contribute to, and may modulate, retinal Netrin-4 levels. This may be a novel pathway of Müller cell-mediated control of retinal angiogenesis, particularly under hypoxic/ischemic conditions when the cells upregulate Netrin-4 expression.
Behnoush A, Khalaji A, Shokri Varniab Z, Rahbarghazi A, Amini E, Klisic A Endocrine. 2023; 84(2):328-344.
PMID: 37996774 DOI: 10.1007/s12020-023-03598-y.
Guo H, Wu H, Li Z Int J Mol Sci. 2023; 24(8).
PMID: 37108143 PMC: 10139109. DOI: 10.3390/ijms24086978.
Retinopathy of prematurity: Metabolic risk factors.
Fu Z, Nilsson A, Hellstrom A, Smith L Elife. 2022; 11.
PMID: 36420952 PMC: 9691009. DOI: 10.7554/eLife.80550.
Netrin-4: Focus on Its Role in Axon Guidance, Tissue Stability, Angiogenesis and Tumors.
Dong F, Liu Y, Yan W, Meng Q, Song X, Cheng B Cell Mol Neurobiol. 2022; 43(5):1663-1683.
PMID: 36350538 PMC: 11412186. DOI: 10.1007/s10571-022-01279-4.
LncRNAs regulate ferroptosis to affect diabetes and its complications.
Chen Q, Ji H, Lin Y, Chen Z, Liu Y, Jin L Front Physiol. 2022; 13:993904.
PMID: 36225311 PMC: 9548856. DOI: 10.3389/fphys.2022.993904.